Nammi Therapeutics
PrivateLast Round
Series B
Nov 8, 2024
Total Funding Raised
$82.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nammi Therapeutics is a biotechnology company that develops innovative immunotherapy solutions, including masked immunocytokines and nanoparticle-based prodrugs, for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nammi Therapeutics Comparables
Compare Nammi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Werewolf Therapeutics | 81% | |
| Asher Biotherapeutics | 80% | |
| CytomX Therapeutics | 79% | |
Nammi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2024 | ||||
| Series B | Aug 6, 2024 | ||||
| Grant | Dec 15, 2022 | ||||
| Seed | Jan 1, 2019 |
Key People
Founding team and executive leadership
Nammi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 40% MoM to 1.8K.
- Dec 15, 2022
$4M grant from California Institute for Regenerative Medicine.
Nammi Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nammi Therapeutics's valuation, stock price, and market status.